SEC Form 4 · accession 0001209191-15-056473
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas G. Cole
Director
Period of report
Jun 23, 2015
Accepted (ET)
Jun 25, 2015 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $103.63 | Jun 23, 2015 | A | 10,625 | A | — | Jun 22, 2025 | Common Stock | 10,625 | 23,125 | D |
Explanation of responses
- F1This option was granted on June 23, 2015. The shares underlying this option vest as to 100% of the underlying shares on June 23, 2016. Mr. Cole is a member of Flagship Ventures 2007 General Partner LLC, the sole general partner of Flagship Ventures Fund 2007, L.P. (the "Fund"). The Fund is a reporting person and has filed Forms 3 and 4 reporting its ownership of shares of the Issuer's common stock. Mr. Cole disclaims beneficial ownership of the Fund's shares, except to the extent of his pecuniary interest therein.